Xiangsheng Zuo
- Cancer Research top 5%
- Cancer, Lipids, and Metabolism 9
- Cancer, Hypoxia, and Metabolism 7
- Biochemistry top 2%
- Oncology top 5%
- Pancreatic and Hepatic Oncology Research 6
- Pharmacology top 5%
- Inflammatory mediators and NSAID effects 13
- Molecular Biology top 5%
- Peroxisome Proliferator-Activated Receptors 13
- Cancer-related gene regulation 4
- Genomics, phytochemicals, and oxidative stress 3
-
- Bioactive Compounds and Antitumor Agents 3
- Co-authors
- Daoyan WeiYongmin YanImad ShureiqiJeffrey S. MorrisLiang WangKeping XieYuanqing WuScott M. Lippman
- Cited by
- Cancer ResearchBiochemistryOncology
- Journals
- Clinical Cancer Research (3 papers)JNCI Journal of the National Cancer Institute (3 papers)Prostaglandins & Other Lipid Mediators (3 papers)
- Partner nations
- United StatesChinaHungary
In The Last Decade
Xiangsheng Zuo
41 papers receiving 2.1k citations
Hit Papers
Peers
Comparison fields: 5 of 96
- Cancer Research 602
- Biochemistry 177
- Oncology 650
- Pharmacology 325
- Molecular Biology 1.3k
Countries citing papers authored by Xiangsheng Zuo
This map shows the geographic impact of Xiangsheng Zuo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiangsheng Zuo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiangsheng Zuo more than expected).
Fields of papers citing papers by Xiangsheng Zuo
This network shows the impact of papers produced by Xiangsheng Zuo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiangsheng Zuo. The network helps show where Xiangsheng Zuo may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xiangsheng Zuo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 6 | |
| 2 | 2023 | 6 | |
| 3 | 2023 | 63 | |
| 4 | 2023 | 2 | |
| 5 | 2022 | 45 | |
| 6 | 2022 | 9 | |
| 7 | 2022 | 27 | |
| 8 | 2021 | 13 | |
| 9 | 2019 | 45 | |
| 10 | 2017 | 36 | |
| 11 | 2017 | 58 | |
| 12 | 2016 | 56 | |
| 13 | 2016 | 109 | |
| 14 | 2012 | 19 | |
| 15 | 2012 | 35 | |
| 16 | 2011 | 37 | |
| 17 | 2011 | 51 | |
| 18 | 2010 | 46 | |
| 19 | 2008 | 20 | |
| 20 | 2005 | 98 |
About Xiangsheng Zuo
Xiangsheng Zuo is a scholar working on Toxicology, Cancer Research and Pharmacology, having authored 41 papers that have together received 2.2k indexed citations. Recurring topics across this work include Peroxisome Proliferator-Activated Receptors (13 papers), Inflammatory mediators and NSAID effects (13 papers), Cancer, Lipids, and Metabolism (9 papers), Cancer, Hypoxia, and Metabolism (7 papers), Pancreatic and Hepatic Oncology Research (6 papers), Cancer-related gene regulation (4 papers), Bioactive Compounds and Antitumor Agents (3 papers) and Genomics, phytochemicals, and oxidative stress (3 papers). The work is most often cited by research in Cancer Research (602 citations), Biochemistry (177 citations) and Oncology (650 citations). Xiangsheng Zuo has collaborated with scholars based in United States, China and Hungary. Frequent co-authors include Daoyan Wei, Yongmin Yan, Imad Shureiqi, Jeffrey S. Morris, Liang Wang, Keping Xie, Yuanqing Wu, Scott M. Lippman, Susan M. Fischer and Micheline J. Moussalli. Their work appears in journals such as Clinical Cancer Research, JNCI Journal of the National Cancer Institute, Prostaglandins & Other Lipid Mediators, The FASEB Journal and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.